Cafepharma Today

January 30 2025 - Novo Nordisk commences fresh trials for CagriSema
Novo Nordisk commences fresh trials for CagriSema
Express Scripts becomes latest PBM to follow in Mark Cuban's footsteps
With efficacy assured, Merck halts another trial of blockbuster-to-be Winrevair
Sanofi plans €5 billion buyback, sees higher profit growth
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Sanofi Chairman Mulls Food Acquisitions to Aid Growth
Bloomberg
Wednesday, March 25, 2009 - 8:37am
tags:
Sanofi, buyouts
Biotech M&A Action: We've Only Just Begun
Seeking Alpha
Wednesday, March 25, 2009 - 8:24am
tags:
biotech, Amgen, Biogen Idec, Genzyme, Gilead Sciences, Merck, Pfizer
Dendreon Disclosure May Endanger Provenge Study
Forbes
Wednesday, March 25, 2009 - 8:22am
tags:
Dendreon, drug trials, prostate cancer, Provenge
Short Interest Rises in Merck and Johnson & Johnson
Seeking Alpha
Wednesday, March 25, 2009 - 8:20am
tags:
Merck, Schering Plough, JNJ
Arena's Financing Deal with Azimuth Is a Healthy Move
Seeking Alpha
Wednesday, March 25, 2009 - 7:44am
tags:
Arena Pharmaceuticals, obesity, Azimuth
Allergan Seeks Own Deals Amid Buyout Talk
TheStreet.com
Wednesday, March 25, 2009 - 7:43am
tags:
Allergan, buyouts, GSK
GSK promises full drug trial disclosure
FT.com
Wednesday, March 25, 2009 - 7:42am
tags:
GSK, drug trials
Wyeth gets expanded FDA approval for antibiotic to treat type of bacterial pneumonia
Yahoo/AP
Wednesday, March 25, 2009 - 7:41am
tags:
Wyeth, FDA, pneumonia, Tygacil
Swiss drugmaker Novartis offers to raise stake in Indian subsidiary to 90 percent
Yahoo/AP
Wednesday, March 25, 2009 - 7:40am
tags:
Novartis, India
Moody's lowers Sanofi-Aventis outlook to stable
Yahoo/AP
Tuesday, March 24, 2009 - 6:47pm
tags:
Sanofi
Taking the F Out of FDA
Motley Fool
Tuesday, March 24, 2009 - 6:46pm
tags:
FDA, Obama
Allergan soars on Glaxo takeover speculation
Marketwatch
Tuesday, March 24, 2009 - 6:30pm
tags:
Allergan, GSK, buyouts
SkyePharma files for Flutiform approval
Fierce Biotech
Tuesday, March 24, 2009 - 9:43am
tags:
Flutiform, SkyePharma, NDA, FDA, asthma
Amylin Shares Find Support, But Upside Still Limited
Seeking Alpha
Tuesday, March 24, 2009 - 9:41am
tags:
Amylin, Eli Lilly, Byetta
NeurogesX Fundamentals Improve
Seeking Alpha
Tuesday, March 24, 2009 - 9:14am
tags:
NeurogesX, Qutenza, neuropathic pain
GSK: Healthcare Is Not Always Defensive
Seeking Alpha
Tuesday, March 24, 2009 - 9:03am
tags:
GSK, JNJ, Sanofi, Pfizer, pipelines
Cubist suing Teva in patent dispute
Yahoo/AP
Tuesday, March 24, 2009 - 8:55am
tags:
Cubist Pharmaceuticals, Teva Pharmaceuticals, patents
Fighting Like a Wolfe Against Johnson & Johnson
InVivo
Tuesday, March 24, 2009 - 7:57am
tags:
JNJ, rivaroxaban
Hospira to cut workforce by about 10%
Marketwatch
Tuesday, March 24, 2009 - 7:55am
tags:
Hospira, layoffs
Merck Updates On $7 Billion In Financing For Schering Buyout
CNN Money
Tuesday, March 24, 2009 - 7:31am
tags:
Merck, Schering Plough, buyouts

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline

Latest Jobs

Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Midland, TX
Midland, Texas, US
Lundbeck
Psychiatry Account Manager - Newport News, VA
Newport News, Virginia, US
Lundbeck
Psychiatry Account Manager - Saint Louis South, MO
Saint Louis, Missouri, US
Lundbeck
Psychiatry Account Manager - Macon, GA
Macon, Georgia, US
Lundbeck
Psychiatry Account Manager - Plano, TX
Plano, Texas, US
Lundbeck
Psychiatry Account Manager - College Station, TX
College Station, Texas, US
Lundbeck
Pharmaceutical Sales Representative- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Manager, Associates Membership Sales
Alexandria, Virginia, United States
Health Industry Distributors Association
Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Jacksonville, Florida
Eli Lilly and Company
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information